Home / Inspections / 1113288

FDA Inspection 1113288 — Oklahoma Blood Institute East Central

Oklahoma Blood Institute East Central — FEI 1641495

The FDA completed an inspection of Oklahoma Blood Institute East Central on Dec 11, 2019 in Ada, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Dec 11, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ada, OK (United States)

Facility

Other inspections at this facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.